Related Experiment Video
Updated: Aug 15, 2026

Using SCOPE to Identify Potential Regulatory Motifs in Coregulated Genes
Published on: May 31, 2011
Regulatory perspectives: one academic viewpoint from the United States
1Neurology, Neuroscience and Psychiatry, Case Western Reserve University, Cleveland, Ohio 44106-7125, USA. pjw3@cwru.edu
Abstract:
The development of new drugs to treat vascular dementia and other conditions in which cognitive impairment is due at least in part to vascular pathology will require future interaction among academic, industry, and government regulatory clinicians and scientists. This article offers the author's perspective on the positive involvement of the Food and Drug Administration in development of conceptual frameworks and practical approaches to treatment of conditions characterized by vascular burden of the brain.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Self Within Cultural Contexts
Global Regulatory Systems
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions